LH saw its Momentum Indicator move above the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned positive. In 60 of the 100 cases, the stock moved higher in the following days. The odds of a move higher are at 60%.
The Moving Average Convergence Divergence (MACD) for LH just turned positive on October 08, 2026. Looking at past instances where LH's MACD turned positive, the stock continued to rise in 27 of 52 cases over the following month. The odds of a continued upward trend are 52%.
LH moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where LH advanced for three days, in 191 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for LH crossed bearishly below the 50-day moving average on September 25, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
LH broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LH entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.051) is normal, around the industry mean (66.046). P/E Ratio (26.602) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (1.206) is also within normal values, averaging (3.473). LH has a moderately high Dividend Yield (0.009) as compared to the industry average of (0.002). P/S Ratio (1.876) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 25 (best 1 - 100 worst), indicating outstanding price growth. LH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The RSI Indicator for NSYS moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 23 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 60 cases where NSYS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +8.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where NSYS advanced for three days, in 181 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
NSYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NSYS as a result. In 79 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NSYS turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 40 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
The 50-day moving average for NSYS moved below the 200-day moving average on October 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSYS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for NSYS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. NSYS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.822) is normal, around the industry mean (2.874). P/E Ratio (27.405) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.267) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSYS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
LH | NSYS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 39 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 45 | 100 | |
SMR RATING 1..100 | 65 | 87 | |
PRICE GROWTH RATING 1..100 | 25 | 63 | |
P/E GROWTH RATING 1..100 | 59 | 59 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LH's Valuation (11) in the Servicestothe Health Industry industry is somewhat better than the same rating for NSYS (74) in the Electronic Components industry. This means that LH’s stock grew somewhat faster than NSYS’s over the last 12 months.
LH's Profit vs Risk Rating (45) in the Servicestothe Health Industry industry is somewhat better than the same rating for NSYS (100) in the Electronic Components industry. This means that LH’s stock grew somewhat faster than NSYS’s over the last 12 months.
LH's SMR Rating (65) in the Servicestothe Health Industry industry is in the same range as NSYS (87) in the Electronic Components industry. This means that LH’s stock grew similarly to NSYS’s over the last 12 months.
LH's Price Growth Rating (25) in the Servicestothe Health Industry industry is somewhat better than the same rating for NSYS (63) in the Electronic Components industry. This means that LH’s stock grew somewhat faster than NSYS’s over the last 12 months.
LH's P/E Growth Rating (59) in the Servicestothe Health Industry industry is in the same range as NSYS (59) in the Electronic Components industry. This means that LH’s stock grew similarly to NSYS’s over the last 12 months.
| LH | NSYS | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 59% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 60% | 1 day ago 75% |
| MACD ODDS (%) | 1 day ago 52% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 58% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 72% |
| Advances ODDS (%) | 1 day ago 57% | 2 days ago 78% |
| Declines ODDS (%) | 22 days ago 53% | 4 days ago 74% |
| BollingerBands ODDS (%) | 1 day ago 62% | 1 day ago 87% |
| Aroon ODDS (%) | 1 day ago 49% | 1 day ago 70% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LH’s FA Score shows that 2 FA rating(s) are green while NSYS’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LH’s TA Score shows that 4 TA indicator(s) are bullish while NSYS’s TA Score has 4 bullish TA indicator(s).
LH (@Medical Specialties) experienced а +1.50% price change this week, while NSYS (@Medical/Nursing Services) price change was +0.38% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.29%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +42.53%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
LH is expected to report earnings on Oct 28, 2026.
NSYS is expected to report earnings on Nov 12, 2026.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, LH has been closely correlated with DGX. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if LH jumps, then DGX could also see price increases.
A.I.dvisor tells us that NSYS and STRR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSYS and STRR's prices will move in lockstep.
| Ticker / NAME | Correlation To NSYS | 1D Price Change % | ||
|---|---|---|---|---|
| NSYS | 100% | -4.61% | ||
| STRR - NSYS | 29% Poorly correlated | -0.92% | ||
| POCI - NSYS | 26% Poorly correlated | -1.86% | ||
| STRRP - NSYS | 23% Poorly correlated | +3.16% | ||
| LH - NSYS | 23% Poorly correlated | +1.91% | ||
| ICUI - NSYS | 23% Poorly correlated | +4.66% | ||
More | ||||